glp-1 drugs lawsuit Receptor Agonists: Drug Litigation Overview and Trends Zepbound Lawsuit [2026] | Gastrointestinal

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

Each serving delivers 78 billion CFUs from a broad range of beneficial strains including Lactobacillus, Bifidobacterium, Akkermansia muciniphila and Christensenella minuta, known for their contribution to a balanced gut microbiome

Novo Nordisk, EVOKE and EVOKE+ phase 3 trial topline results, Alzheimers Association statement, 2025

Learn how GLP-1 receptor agonists help patients with type 2 diabetes and obesity manage blood sugar, lose weight, and protect heart health.

ADDITIONAL DETAILS: Live Probiotics, Prebiotic Fiber, and a Key Postbiotic for Daily Support

Discover how naturopathy supports natural GLP-1 production and improves insulin resistance through gut health, nutrition, stress management, and lifestyle changes.